← Leaderboards
Giovanni Ligresti
Mayo Clinic Rochester
$4,830,216
Attributed
$4,830,216
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,830,216 · 2
By mechanism
R01$4,830,216 · 2
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Daniel J. Tschumperlin$19,462,790
- Sundeep Khosla$91,221,003
- Malay Choudhury$1,908,593
- Douglas Glenn Brownfield$3,479,245
- Eduardo N Chini$9,940,387
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsOverexpressionIn VitroInflammationLungMediatingGenome-WideGenetic TranscriptionHistonesIdiopathic Pulmonary FibrosisBindingFibrosisBleomycinLung InjuryDisease ProgressionCoupledGenesDeep SequencingAttenuatedFibroblastsEpigenetic ProcessExperimental StudyChronicPulmonary Fibrosis
Grant awards (9)
Targeting vascular dysfunction to promote lung repair and fibrosis resolution$693,152
R01 · FY2025 · HL · contact PI
Targeting vascular dysfunction to promote lung repair and fibrosis resolution$679,288
R01 · FY2024 · HL · contact PI
Targeting vascular dysfunction to promote lung repair and fibrosis resolution$693,152
R01 · FY2023 · HL · contact PI
Targeting vascular dysfunction to promote lung repair and fibrosis resolution$717,124
R01 · FY2022 · HL · contact PI
Epigenetic gene repression in pulmonary fibrosis$412,500
R01 · FY2022 · HL · contact PI
Epigenetic gene repression in pulmonary fibrosis$412,500
R01 · FY2021 · HL · contact PI
Epigenetic gene repression in pulmonary fibrosis$412,500
R01 · FY2020 · HL · contact PI
Epigenetic gene repression in pulmonary fibrosis$412,500
R01 · FY2019 · HL · contact PI
Epigenetic gene repression in pulmonary fibrosis$397,500
R01 · FY2018 · HL · contact PI